Home   Chapter Home   Jobs   Conferences    Fellowships    Books



HPV testing

Reviewer: (see Reviewers page)
Revised: 17 September 2010, last major update August 2010
Copyright: (c) 2006-2010, PathologyOutlines.com, Inc.

Definition / general
======================================================================== =

● HPV testing may be more sensitive than cytology in detecting HSIL (Br J Cancer 2005;93:575)
● Prevalence of HPV DNA positivity, clinical value of HPV test and positive predictive value for dysplasia varies according to age group (American Journal of Obstetrics and Gynecology 2007;197(4), 346-355)
● HPV testing is an integral part of management of ASCUS (atypical squamous cells of uncertain significance), ASC-H (atypical squamous cells, cannot exclude HSIL) and to evaluate AGUS (atypical glandular cells, Am J Obstet Gynecol 2005;193:559)
● Study of simultaneous FISH for HPV E6 and E7 mRNA had 83% sensitivity and 91% sensitivity for high grade SIL compared with Pap smear in 231 liquid based cytology samples (Am J Clin Path 2005;123:716)

Additional references

● http://www.guideline.gov/content.aspx?id=13491&search=cervix

End of Cervix-cytology > HPV testing

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).